Literature DB >> 12818708

Animal models in the investigation of anorexia.

Zahava Siegfried1, Elliot M Berry, Shuzhen Hao, Yosefa Avraham.   

Abstract

Anorexia nervosa (AN) is an eating disorder of unknown origin that most commonly occurs in women and usually has its onset in adolescence. Patients with AN invariably have a disturbed body image and an intense fear of weight gain. There is currently no definitive treatment for this disease, which carries a 20% mortality over 20 years. Development of an appropriate animal model of AN has been difficult, as the etiology of this eating disorder likely involves a complex interaction between genetic, environmental, social, and cultural factors. In this review, we focus on several possible rodent models of AN. In our laboratory, we have developed and studied three different mouse models of AN based on clinical profiles of the disease; separation stress, activity, and diet restriction (DR). In addition, we discuss the spontaneous mouse mutation anx/anx and several mouse gene knockout models, which have resulted in an anorexic phenotype. We highlight what has been learned from each of these models and possibilities for future models. It is hoped that a combination of the study of such models, together with genetic and clinical studies in patients, will lead to more rational and successful prevention/treatment of this tragic, and often fatal, disease.

Entities:  

Mesh:

Year:  2003        PMID: 12818708     DOI: 10.1016/s0031-9384(03)00103-3

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  16 in total

Review 1.  Neuroendocrinology of reward in anorexia nervosa and bulimia nervosa: Beyond leptin and ghrelin.

Authors:  Laura A Berner; Tiffany A Brown; Jason M Lavender; Emily Lopez; Christina E Wierenga; Walter H Kaye
Journal:  Mol Cell Endocrinol       Date:  2018-11-02       Impact factor: 4.102

Review 2.  Relevance of animal models to human eating disorders and obesity.

Authors:  Regina C Casper; Elinor L Sullivan; Laurence Tecott
Journal:  Psychopharmacology (Berl)       Date:  2008-03-04       Impact factor: 4.530

Review 3.  Pharmacological manipulations in animal models of anorexia and binge eating in relation to humans.

Authors:  M A van Gestel; E Kostrzewa; R A H Adan; S K Janhunen
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

4.  Assessing Activity-based Anorexia in Mice.

Authors:  Amanda C Welch; William R Katzka; Stephanie C Dulawa
Journal:  J Vis Exp       Date:  2018-05-14       Impact factor: 1.355

5.  The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia.

Authors:  Aaron N A Verty; Megan J Evetts; Geraldine J Crouch; Iain S McGregor; Aneta Stefanidis; Brian J Oldfield
Journal:  Neuropsychopharmacology       Date:  2011-03-16       Impact factor: 7.853

Review 6.  Sex differences in the physiology of eating.

Authors:  Lori Asarian; Nori Geary
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-07-31       Impact factor: 3.619

7.  Melanin-concentrating hormone is necessary for olanzapine-inhibited locomotor activity in male mice.

Authors:  Melissa J S Chee; Nicholas Douris; Avery B Forrow; Arnaud Monnard; Shuangyu Lu; Stephen E Flaherty; Andrew C Adams; Eleftheria Maratos-Flier
Journal:  Eur Neuropsychopharmacol       Date:  2015-06-03       Impact factor: 4.600

8.  Adolescent female C57BL/6 mice with vulnerability to activity-based anorexia exhibit weak inhibitory input onto hippocampal CA1 pyramidal cells.

Authors:  T G Chowdhury; G S Wable; N A Sabaliauskas; C Aoki
Journal:  Neuroscience       Date:  2013-03-21       Impact factor: 3.590

Review 9.  Interspecies genetics of eating disorder traits.

Authors:  Martien J H Kas; Walter H Kaye; Wendy Foulds Mathes; Cynthia M Bulik
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-04-05       Impact factor: 3.568

10.  Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1.

Authors:  Brian Onken; Monica Driscoll
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.